Metraipolis › archive › dc_dbf36905244b

Good response with nivolumab and cabozantinib combination therapy in patients with metastatic collecting duct carcinoma with high expression of PD-L1, c-MET,… — Europe PMC PMID:40921965

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40921965
DOI
10.1007/s13730-[numero omesso]-9
License (as archived)
solo-consultazione
Archived
2026-11-10T02:16:29.047Z
SHA-256 of the archived text
f0384770e366ae041a1b382ad527028eb7c1b63f768676e6d7cf52859376df94
Stable URL of this page
https://metraipolis.com/documento/dc_dbf36905244b

How to cite

Good response with nivolumab and cabozantinib combination therapy in patients with metastatic collecting duct carcinoma with high expression of PD-L1, c-MET,… — Europe PMC PMID:40921965 — Europe PMC (en), https://europepmc.org/article/MED/40921965 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dbf36905244b (Metraipolis archive dc_dbf36905244b, sha256 f0384770e366ae041a1b382ad527028eb7c1b63f768676e6d7cf52859376df94)
BibTeX
@misc{dcdbf36905244b,
  title = {Good response with nivolumab and cabozantinib combination therapy in patients with metastatic collecting duct carcinoma with high expression of PD-L1, c-MET,… — Europe PMC PMID:40921965},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40921965},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dbf36905244b; sha256 f0384770e366ae041a1b382ad527028eb7c1b63f768676e6d7cf52859376df94},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40921965. Agents can read the archived copy with the MCP tool read_document.